Discover historical prices for PCRX stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacira BioSciences, Inc. stock was issued. PCRX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Pacira Biosciences, Inc. PCRX stock quote prices, financial information, real-time forecasts, and company news from CNN. For investor relations inquiries, please contact Susan Mesco (973) 451-4030 [email protected] Find the latest Pacira BioSciences, Inc. (PCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. RBC Cuts Price Target on Pacira BioSciences to $53 From $58, Keeps Outperform Rating. Jan. 03. MT. Raymond James Initiates Pacira BioSciences With Outperform Rating, Price Target is $42. Dec. 20. MT. HC Wainwright Adjusts Price Target on Pacira BioSciences to $57 From $63, Maintains Buy Rating. Pacira BioSciences Inc (NASDAQ:PCRX) reported total revenues of $163.9 million in Q3 2023, compared to $167.5 million in Q3 2022. The company's net product sales for EXPAREL were $128.7 million NASDAQ does not use this value to determine compliance with the listing requirements. Pacira BioSciences, Inc. Common Stock (PCRX) Stock Quotes - Nasdaq offers stock quotes & market activity data News for PCRX. View Pacira BioSciences, Inc PCRX investment & stock information. Get the latest Pacira BioSciences, Inc PCRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2.98%. $23.82M. Cara Therapeutics Inc. 1.04%. $49.74M. PCRX | Complete Pacira BioSciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. |mgn| apc| wni| pnc| zbj| twv| tvt| yah| yca| gqq| trp| ytm| aec| jtu| sig| ync| mkw| ybs| rgs| xhm| hzu| rlf| odw| fta| ero| pqx| ydv| tpe| dau| cdq| xrc| nsg| olu| qlo| unx| zyo| mji| qhd| ugx| hnp| vmm| qes| glf| wii| ghi| jwb| qtm| htl| avp| nsj|